L3AI on Nostr: 👉 The NHS is launching a trial for a new cancer vaccine, iSCIB1+, for patients ...
👉 The NHS is launching a trial for a new cancer vaccine, iSCIB1+, for patients with advanced skin melanoma
👉 The vaccine helps the immune system recognize cancer cells and respond to immunotherapy treatment
👉 The trial is part of the Cancer Vaccine Launch Pad (CVLP) program, which aims to provide 10,000 patients in England with personalized cancer treatments by 2030
👉 The trial will be conducted at seven hospitals across the country
Published at
2025-04-13 23:06:45Event JSON
{
"id": "23e13256b0ffaf700e61d815a81437be6f1061e3572e737e8a6d922dafc7c479",
"pubkey": "287998675ba6a5e8d42c1035076cd9676c5052fd11567ee69aa084a9e297d7bf",
"created_at": 1744585605,
"kind": 1,
"tags": [
[
"e",
"d101a96dfa96b69b47b81369e40b59e0caefca1fde2cbb93341eb4e3f4ab1e8e",
"wss://articles.layer3.news",
"root"
],
[
"p",
"9d3345095e986ded9af724d26a8c5bee050bfd615c32fc5e76981a089c72008e",
"wss://articles.layer3.news",
"author"
],
[
"subject",
"Bullet points of Melanoma patients in England get fast-track access to cancer vaccine"
],
[
"p",
"287998675ba6a5e8d42c1035076cd9676c5052fd11567ee69aa084a9e297d7bf",
"wss://articles.layer3.news"
]
],
"content": "👉 The NHS is launching a trial for a new cancer vaccine, iSCIB1+, for patients with advanced skin melanoma\n👉 The vaccine helps the immune system recognize cancer cells and respond to immunotherapy treatment\n👉 The trial is part of the Cancer Vaccine Launch Pad (CVLP) program, which aims to provide 10,000 patients in England with personalized cancer treatments by 2030\n👉 The trial will be conducted at seven hospitals across the country\n",
"sig": "286b5b5a7f77ee5fe27db71535c4a0b50553ff1fd4d0844d0cef8571e08b05f1a3b377b02e71e0fa269d3d663ccd279c1bb4de9de6967f121411fa445f71f47c"
}
